According to Fortune Business Insights, the global glaucoma surgery devices market size was valued at USD 1.55 billion in 2025 and is projected to grow from USD 1.64 billion in 2026 to USD 2.48 billion by 2034, exhibiting a CAGR of 5.3% during the forecast period. North America dominated the global glaucoma surgery devices market with a market share of 36.13% in 2025.
The market is witnessing steady growth due to the rising prevalence of glaucoma, increasing geriatric population, growing adoption of minimally invasive glaucoma surgery procedures, and advancements in ophthalmic surgical technologies. Expanding access to specialized eye care services and increasing awareness of early glaucoma diagnosis and treatment are further supporting market growth.
Key Market Drivers
Rising Prevalence of Glaucoma
The growing number of patients diagnosed with glaucoma is increasing demand for effective surgical interventions and advanced ophthalmic devices.
Growing Adoption of Minimally Invasive Glaucoma Surgery
Increasing preference for minimally invasive procedures with shorter recovery periods and reduced surgical complications is supporting demand for advanced glaucoma surgery devices.
Advancements in Ophthalmic Surgical Technologies
Continuous innovation in drainage implants, micro-stents, laser systems, and precision surgical instruments is improving glaucoma treatment outcomes.
Market Restraints
High Cost of Advanced Surgical Devices
The cost of innovative glaucoma surgery devices and procedures may limit adoption, particularly in developing healthcare markets.
Limited Availability of Skilled Ophthalmic Surgeons
A shortage of trained ophthalmologists and glaucoma specialists can restrict access to advanced surgical procedures in certain regions.
Get Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/glaucoma-surgery-devices-market-116145
Market Opportunities
Expansion of Minimally Invasive Surgical Technologies
Increasing research and product development activities focused on next-generation minimally invasive glaucoma surgery devices are creating significant market opportunities.
Growing Demand for Ophthalmic Care in Emerging Markets
Improving healthcare infrastructure, increasing awareness of eye diseases, and expanding access to specialized ophthalmic treatment are supporting market expansion.
Segmentation
By Device Type
- Glaucoma Drainage Devices
- Minimally Invasive Surgery Devices
- Traditional Surgery Devices & Consumables
- Laser Systems
- Others
By Procedure Type
- Traditional Surgery
- Minimally Invasive Surgery
- Laser Surgery
By End-user
- Hospitals & ASCs
- Specialty Clinics
- Others
Regional Insights
North America
North America dominated the glaucoma surgery devices market with a share of 36.13% in 2025. The region benefits from advanced healthcare infrastructure, high adoption of innovative ophthalmic technologies, increasing prevalence of glaucoma, and strong availability of specialized eye care facilities.
Europe
Europe is witnessing steady growth due to increasing geriatric populations, expanding glaucoma screening programs, and growing adoption of minimally invasive ophthalmic procedures.
Asia Pacific
Asia Pacific is expected to register significant growth during the forecast period owing to a large patient population, improving healthcare infrastructure, increasing awareness of glaucoma treatment, and expanding access to specialized ophthalmic care.
Rest of the World
Latin America and the Middle East & Africa are gradually expanding the adoption of glaucoma surgery devices as investments in healthcare infrastructure and access to advanced ophthalmic procedures increase.
Get Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/glaucoma-surgery-devices-market-116145
Key Players in the Glaucoma Surgery Devices Market
- Alcon Inc.
- AbbVie Inc.
- Glaukos Corporation
- Johnson & Johnson
- Bausch + Lomb Corporation
- Carl Zeiss Meditec AG
- IRIDEX Corporation
- New World Medical, Inc.
- Lumenis Ltd.
- Santen Pharmaceutical Co., Ltd.
Conclusion
The global glaucoma surgery devices market is expected to witness steady growth through 2034, driven by the rising prevalence of glaucoma, increasing adoption of minimally invasive surgical procedures, and continuous advancements in ophthalmic technologies. Growing investments in innovative glaucoma devices, expanding specialized eye care services, and improving access to advanced surgical treatments are expected to create significant growth opportunities for market participants during the forecast period.